nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—SLC6A4—attention deficit hyperactivity disorder	0.863	1	CbGaD
Dexfenfluramine—Methamphetamine—ADRA2C—attention deficit hyperactivity disorder	0.00305	0.371	CrCbGaD
Dexfenfluramine—Methamphetamine—MAOA—attention deficit hyperactivity disorder	0.00154	0.188	CrCbGaD
Dexfenfluramine—Methamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00133	0.162	CrCbGaD
Dexfenfluramine—Methamphetamine—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.158	CrCbGaD
Dexfenfluramine—Methamphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000994	0.121	CrCbGaD
Dexfenfluramine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000842	0.072	CbGeAlD
Dexfenfluramine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000798	0.0682	CbGeAlD
Dexfenfluramine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000791	0.0676	CbGeAlD
Dexfenfluramine—HTR2B—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000742	0.00633	CbGpPWpGaD
Dexfenfluramine—HTR2C—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000713	0.00607	CbGpPWpGaD
Dexfenfluramine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000669	0.0572	CbGeAlD
Dexfenfluramine—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000623	0.00531	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000605	0.00516	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000599	0.00511	CbGpPWpGaD
Dexfenfluramine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000556	0.0475	CbGeAlD
Dexfenfluramine—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000542	0.00462	CbGpPWpGaD
Dexfenfluramine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000527	0.0451	CbGeAlD
Dexfenfluramine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000525	0.0449	CbGeAlD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00052	0.00443	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000504	0.00429	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000499	0.00425	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000494	0.00421	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000493	0.0042	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00049	0.00418	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000484	0.00412	CbGpPWpGaD
Dexfenfluramine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000457	0.0391	CbGeAlD
Dexfenfluramine—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000455	0.00387	CbGpPWpGaD
Dexfenfluramine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00044	0.0376	CbGeAlD
Dexfenfluramine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000434	0.0371	CbGeAlD
Dexfenfluramine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000433	0.037	CbGeAlD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000431	0.00368	CbGpPWpGaD
Dexfenfluramine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000429	0.0367	CbGeAlD
Dexfenfluramine—CYP2A6—brain—attention deficit hyperactivity disorder	0.000427	0.0365	CbGeAlD
Dexfenfluramine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000423	0.0036	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000423	0.0036	CbGpPWpGaD
Dexfenfluramine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000417	0.0357	CbGeAlD
Dexfenfluramine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000414	0.0353	CbGeAlD
Dexfenfluramine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000411	0.0351	CbGeAlD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000406	0.00346	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000403	0.00344	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000398	0.00339	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000395	0.00337	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000395	0.00337	CbGpPWpGaD
Dexfenfluramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000385	0.0329	CbGeAlD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000382	0.00326	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000371	0.00316	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000364	0.0031	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000351	0.00299	CbGpPWpGaD
Dexfenfluramine—HTR2C—brain—attention deficit hyperactivity disorder	0.000349	0.0299	CbGeAlD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000348	0.00297	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000346	0.00295	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000342	0.00291	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000341	0.00291	CbGpPWpGaD
Dexfenfluramine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000331	0.0283	CbGeAlD
Dexfenfluramine—HTR2B—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000329	0.0028	CbGpPWpGaD
Dexfenfluramine—HTR2B—brain—attention deficit hyperactivity disorder	0.000328	0.0281	CbGeAlD
Dexfenfluramine—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000324	0.00277	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000322	0.00274	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000319	0.00272	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000299	0.00255	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000297	0.00253	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000293	0.0025	CbGpPWpGaD
Dexfenfluramine—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000289	0.00247	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000278	0.00237	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000277	0.00236	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000276	0.00235	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000269	0.00229	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000265	0.00226	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000264	0.00225	CbGpPWpGaD
Dexfenfluramine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000264	0.0225	CbGeAlD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000261	0.00223	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00026	0.00221	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000256	0.00218	CbGpPWpGaD
Dexfenfluramine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000254	0.0217	CbGeAlD
Dexfenfluramine—HTR2B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000251	0.00214	CbGpPWpGaD
Dexfenfluramine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000248	0.0212	CbGeAlD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000246	0.0021	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000243	0.00207	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000241	0.00206	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000238	0.00203	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000236	0.00201	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000231	0.00197	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000227	0.00193	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000226	0.00193	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000224	0.00191	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000224	0.00191	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000224	0.00191	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000223	0.0019	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000223	0.0019	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00022	0.00188	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000217	0.00185	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000216	0.00184	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000214	0.00183	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000213	0.00182	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000211	0.0018	CbGpPWpGaD
Dexfenfluramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000209	0.0179	CbGeAlD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000208	0.00178	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000207	0.00176	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000203	0.00173	CbGpPWpGaD
Dexfenfluramine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000202	0.0172	CbGeAlD
Dexfenfluramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000201	0.0172	CbGeAlD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000197	0.00168	CbGpPWpGaD
Dexfenfluramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000197	0.0168	CbGeAlD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000196	0.00167	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000195	0.00166	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000192	0.00164	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000192	0.00163	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000186	0.00159	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000186	0.00158	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000183	0.00156	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000182	0.00155	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000181	0.00155	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000181	0.00154	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00018	0.00153	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000178	0.00152	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000176	0.0015	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000175	0.00149	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.00147	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00017	0.00145	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00017	0.00145	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00017	0.00145	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000169	0.00144	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000169	0.00144	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000168	0.00143	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000168	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000165	0.00141	CbGpPWpGaD
Dexfenfluramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00016	0.0136	CbGeAlD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000159	0.00136	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000159	0.00135	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000157	0.00134	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000157	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00015	0.00128	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000148	0.00127	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000147	0.00125	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000146	0.00125	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000146	0.00124	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000142	0.00121	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000139	0.00119	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000138	0.00117	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000137	0.00117	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000136	0.00116	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000133	0.00114	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000132	0.00112	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000131	0.00111	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00013	0.00111	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000128	0.00109	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000128	0.00109	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000126	0.00108	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000126	0.00108	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000126	0.00107	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000121	0.00103	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00012	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00012	0.00102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00012	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000119	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000119	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000118	0.00101	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000118	0.001	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000116	0.000988	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000114	0.000976	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000111	0.000948	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00011	0.000939	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000102	0.000874	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000102	0.000873	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000102	0.000867	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000102	0.000867	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000101	0.000862	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0001	0.000853	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	9.96e-05	0.000849	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	9.92e-05	0.000846	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.76e-05	0.000832	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	9.75e-05	0.000831	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	9.63e-05	0.000821	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	9.57e-05	0.000816	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	9.35e-05	0.000797	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.3e-05	0.000793	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	9.24e-05	0.000787	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.01e-05	0.000768	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.97e-05	0.000765	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.97e-05	0.000765	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	8.89e-05	0.000758	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.86e-05	0.000755	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.82e-05	0.000752	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.75e-05	0.000746	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	8.26e-05	0.000705	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.15e-05	0.000695	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.07e-05	0.000688	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.03e-05	0.000685	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8e-05	0.000682	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.87e-05	0.000671	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.87e-05	0.000671	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.77e-05	0.000662	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.72e-05	0.000658	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.51e-05	0.00064	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.27e-05	0.00062	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.24e-05	0.000617	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.14e-05	0.000609	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.06e-05	0.000602	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.97e-05	0.000594	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.76e-05	0.000576	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.57e-05	0.00056	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.28e-05	0.000536	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	6.09e-05	0.000519	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.09e-05	0.000519	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	5.99e-05	0.000511	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.91e-05	0.000504	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.71e-05	0.000486	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.57e-05	0.000475	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.5e-05	0.000468	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.46e-05	0.000465	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.38e-05	0.000458	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.32e-05	0.000454	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.23e-05	0.000446	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.17e-05	0.00044	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.07e-05	0.000432	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.95e-05	0.000422	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.9e-05	0.000418	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.87e-05	0.000415	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.81e-05	0.00041	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.81e-05	0.00041	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.81e-05	0.00041	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.77e-05	0.000407	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.73e-05	0.000404	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.63e-05	0.000395	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.6e-05	0.000392	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.43e-05	0.000378	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.4e-05	0.000375	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.29e-05	0.000366	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.22e-05	0.00036	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.19e-05	0.000357	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.17e-05	0.000355	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.88e-05	0.000331	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.85e-05	0.000328	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	3.71e-05	0.000316	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.71e-05	0.000316	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	3.69e-05	0.000314	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.66e-05	0.000312	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.66e-05	0.000312	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	3.65e-05	0.000311	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.41e-05	0.000291	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.41e-05	0.000291	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.4e-05	0.000289	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	3.38e-05	0.000289	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.38e-05	0.000289	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.37e-05	0.000287	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.36e-05	0.000286	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	3.33e-05	0.000284	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.12e-05	0.000266	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.1e-05	0.000264	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.97e-05	0.000253	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	2.92e-05	0.000248	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.89e-05	0.000247	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	2.89e-05	0.000247	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.89e-05	0.000247	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.85e-05	0.000243	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.83e-05	0.000241	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.73e-05	0.000233	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.72e-05	0.000232	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.71e-05	0.000231	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.65e-05	0.000226	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.6e-05	0.000222	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.58e-05	0.00022	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.31e-05	0.000197	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	2.25e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	2.23e-05	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.2e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.17e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	2.07e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.05e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	2.05e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	2.04e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.97e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.79e-05	0.000152	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.75e-05	0.000149	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.74e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.69e-05	0.000144	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	1.58e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.44e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	1.25e-05	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	9.64e-06	8.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	8.87e-06	7.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	8.79e-06	7.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.52e-06	6.41e-05	CbGpPWpGaD
